Scarica l'app Stockscreener
7.90
1.94%
0.15
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AVDL Giù?
Forum
Previsione
Precedente Chiudi:
$7.75
Aprire:
$7.93
Volume 24 ore:
2.25M
Relative Volume:
1.61
Capitalizzazione di mercato:
$761.26M
Reddito:
$47.56M
Utile/perdita netta:
$-156.83M
Rapporto P/E:
-4.3169
EPS:
-1.83
Flusso di cassa netto:
$-127.98M
1 W Prestazione:
-1.86%
1M Prestazione:
-23.38%
6M Prestazione:
-51.23%
1 anno Prestazione:
-47.26%
Intervallo 1D:
$7.63
$8.025
Intervallo di 1 settimana:
$7.63
$8.74
Portata 52W:
$7.39
$19.09
Avadel Pharmaceuticals Plc Stock (AVDL) Company Profile
Nome
Avadel Pharmaceuticals Plc
Settore
Telefono
636-449-1830
Indirizzo
BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK, DUBLIN
Confronta AVDL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AVDL
Avadel Pharmaceuticals Plc
|
7.90 | 761.26M | 47.56M | -156.83M | -127.98M | -1.83 |
|
ZTS
Zoetis Inc
|
167.53 | 75.58B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.24 | 41.78B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.10 | 41.53B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
21.82 | 24.72B | 16.77B | -959.00M | 1.37B | -0.85 |
|
NBIX
Neurocrine Biosciences Inc
|
145.88 | 14.77B | 2.24B | 385.90M | 440.10M | 3.73 |
Avadel Pharmaceuticals Plc Stock (AVDL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-06-12 | Iniziato | Rodman & Renshaw | Buy |
| 2024-03-05 | Reiterato | H.C. Wainwright | Buy |
| 2024-03-05 | Reiterato | Needham | Buy |
| 2024-03-05 | Reiterato | Oppenheimer | Outperform |
| 2024-02-06 | Iniziato | UBS | Buy |
| 2022-11-30 | Aggiornamento | Jefferies | Hold → Buy |
| 2022-08-10 | Downgrade | Jefferies | Buy → Hold |
| 2022-07-28 | Ripresa | Craig Hallum | Buy |
| 2022-05-26 | Downgrade | Stifel | Buy → Hold |
| 2021-09-23 | Iniziato | Needham | Buy |
| 2020-07-31 | Iniziato | Oppenheimer | Outperform |
| 2020-07-21 | Iniziato | SVB Leerink | Outperform |
| 2020-06-30 | Iniziato | H.C. Wainwright | Buy |
| 2020-04-03 | Iniziato | Jefferies | Buy |
| 2020-03-12 | Iniziato | Stifel | Buy |
| 2020-02-26 | Iniziato | Piper Sandler | Overweight |
| 2020-01-30 | Iniziato | Craig Hallum | Buy |
| 2019-06-14 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2019-02-08 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
Mostra tutto
Avadel Pharmaceuticals Plc Borsa (AVDL) Ultime notizie
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Given Average Rating of "Buy" by Analysts - MarketBeat
There May Still Be Time to Get in on These 3 Trending Biotechs - MarketBeat
Avadel Pharmaceuticals (NASDAQ:AVDL) Shares Gap Up Following Insider Buying Activity - MarketBeat
Avadel Pharmaceuticals director Peter Thornton buys shares worth $80,450 By Investing.com - Investing.com Australia
Avadel Pharmaceuticals director Peter Thornton buys shares worth $80,450 - Investing.com India
Insider Buying: Peter Thornton Acquires 10,000 Shares of Avadel Pharmaceuticals PLC - GuruFocus.com
Peter J. Thornton Purchases 10,000 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL) Stock - MarketBeat
Avadel Pharmaceuticals director Eric Ende buys $235,218 in shares By Investing.com - Investing.com South Africa
Avadel Pharmaceuticals director Eric Ende buys $235,218 in shares - Investing.com
Avadel Pharmaceuticals (NASDAQ:AVDL) Given New $14.00 Price Target at UBS Group - MarketBeat
What is Lifesci Capital's Forecast for AVDL FY2024 Earnings? - MarketBeat
Avadel Pharmaceuticals: Patient Attrition Weighs On 2025 Outlook (NASDAQ:AVDL) - Seeking Alpha
Avadel Pharmaceuticals (NASDAQ:AVDL) Price Target Lowered to $13.00 at Piper Sandler - MarketBeat
Avadel Pharmaceuticals (NASDAQ:AVDL) Hits New 52-Week Low After Analyst Downgrade - MarketBeat
Avadel Pharmaceuticals (NASDAQ:AVDL) Earns Buy Rating from HC Wainwright - MarketBeat
Avadel reports strong Q4 growth for narcolepsy drug LUMRYZ By Investing.com - Investing.com Australia
Avadel Pharmaceuticals (NASDAQ:AVDL) Price Target Cut to $19.00 by Analysts at Needham & Company LLC - MarketBeat
Avadel Pharmaceuticals plc Provides Update on Revitalyz Pivotal Study - Marketscreener.com
Avadel Pharmaceuticals Misses Earnings Estimates But Posts 150% Sales Increase From Narcolepsy Drug LUMRYZ - Benzinga
Avadel announces preliminary Q4 net product revenue of $50 million - MSN
AVDLAvadel Pharmaceuticals plc Ordinary Share Latest Stock News & Market Updates - StockTitan
After-hours movers: NVIDIA, Costco, Penguin Solutions, Avadel Pharma By Investing.com - Investing.com Nigeria
Avadel reports strong Q4 growth for narcolepsy drug LUMRYZ - Investing.com
Avadel Pharmaceuticals Projects Robust Growth for LUMRYZ - TipRanks
Avadel Pharmaceuticals falls as Q4 revenue misses estimates; shares sink 20% - Investing.com Nigeria
Avadel Pharmaceuticals falls as Q4 revenue misses estimates; shares sink 20% By Investing.com - Investing.com South Africa
Avadel Announces Preliminary 2024 Results and 2025 Commercial Priorities to Accelerate the LUMRYZ Launch - The Manila Times
Avadel's LUMRYZ Narcolepsy Drug Hits $50M in Q4, Patient Base Surges 275% as Growth Accelerates - StockTitan
Avadel Pharmaceuticals PLC (AVDL) Q4 2024 Earnings Report Previe - GuruFocus.com
Avadel Pharmaceuticals PLC (AVDL) Q4 2024 Earnings Report Preview: What To Expect - Yahoo Finance
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Avadel Pharmaceuticals Grants Stock Options to 12 New Employees in Strategic Talent Expansion - StockTitan
Avadel Pharmaceuticals to Provide a Corporate Update and Preliminary Fourth Quarter and Full Year 2024 Financial Highlights on January 8 - The Manila Times
Avadel Pharmaceuticals Schedules Q4 & Full Year 2024 Financial Results Conference Call - StockTitan
Geode Capital Management LLC Has $15.14 Million Stake in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Stifel Financial Corp Sells 1,452 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Receives $24.43 Consensus Price Target from Analysts - MarketBeat
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Given Average Rating of “Buy” by Analysts - Defense World
Fmr LLC Makes New $31,000 Investment in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Shares Purchased by State Street Corp - Defense World
State Street Corp Raises Position in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - MarketBeat
How the (AVDL) price action is used to our Advantage - Stock Traders Daily
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Makes New $484,000 Investment in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Barclays PLC Buys 123,430 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL) - MarketBeat
C-Suite Buy of the Week: Unusual Insider Trading Trends as 2025 Approaches - Benzinga
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Shares Purchased by Lord Abbett & CO. LLC - MarketBeat
Avadel Pharmaceuticals Plc Azioni (AVDL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.14%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):